IL17A and stroke disorder: Interleukin-17 (IL-17), produced primarily by infiltrating T-helper 17 (Th17) and γδ T cells, shows a delayed elevation beginning around 48–72 h post-stroke, coinciding with later-stage T-cell infiltration and extended inflammation [32].